Illumina (ILMN.O) said on Monday it had filed a registration statement with the U.S. securities regulator related to a potential divestiture of Grail (GRAL.O), even as it challenges a European Union order to divest the cancer test maker in court.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,